My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions, conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts.
About Us
Plans & Pricing
Bioventus (BVS)
NASDAQ:BVS
BVS nasdaq
United States
Bioventus

Bioventus Stock Analysis & Ratings

Bioventus Stock Analysis Overview

Smart Score
5
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
The Bioventus stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.

Stock Chart

BVS

BVS Stock Stats

Previous Close$13.97
Open$14.11
Bid13.94 x 1
Ask14.26 x 1
Today’s Range$13.97 - $14.11
52-Week Range$10.74 - $19.94
Volume3.78K
Average Volume160.20K
Market Cap$794.19M
Beta0.24
P/E Ratio19.6
EPS0.71
Earnings DateMar 24, 2022

Company Description

Bioventus

Bioventus Inc is a medical technology company incorporated in Delaware on December 22, 2015. The Company is engaged in developing and commercializing orthobiologic products for the treatment of patients suffering from a broad array of musculoskeletal conditions. Its products address the growing need for clinically effective, cost efficient and minimally invasive solutions that enhance the body's natural healing processes. The Company operates through four segments including Active Healing Therapies-U.S., Active Healing Therapies-International, Surgical and BMP. The Company's Active Healing Therapies segments offer two types of non-surgical products including non-invasive Exogen system for long bone stimulation for fracture healing and hyaluronic acid, or HA, viscosupplementation therapies for osteoarthritis pain relief.
Sector
Healthcare
Industry
Medical Diagnostics & Research
CEO
Kenneth M. Reali
Employees
900
ISIN
US09075A1088
Address
4721 Emperor Boulevard, Durham, NC, 27703, US

Financials


P/E Ratio Range

Currently, no data available
Please return soon. This page is being updated.
The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

BVS FAQ

What was Bioventus’s price range in the past 12 months?
Bioventus lowest stock price was $10.74 and its highest was $19.94 in the past 12 months.
    What is Bioventus’s market cap?
    Bioventus’s market cap is $794.19M.
      What is Bioventus’s price target?
      Currently, no data Available
      What do analysts say about Bioventus?
      Not enough analysts have published a price target to provide an average price target.
      When is Bioventus’s upcoming earnings report date?
      Bioventus’s upcoming earnings report date is Mar 24, 2022 which is in 5 months.
        How were Bioventus’s earnings last quarter?
        Bioventus released its earnings results on Aug 10, 2021. The company reported -$0.099 earnings per share for the quarter, missing the consensus estimate of $0.137 by -$0.236.
          Is Bioventus overvalued?
          According to Wall Street analysts Bioventus’s price is currently Overvalued.
            Does Bioventus pay dividends?
            Bioventus does not currently pay dividends.
            What is Bioventus’s EPS estimate?
            Bioventus’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Bioventus have?
            Bioventus has 56,850,000 shares outstanding.
              What happened to Bioventus’s price movement after its last earnings report?
              Bioventus reported an EPS of -$0.099 in its last earnings report, missing expectations of $0.137. Following the earnings report the stock price went up 1.73%.
                Which hedge fund is a major shareholder of Bioventus?
                Among the largest hedge funds holding Bioventus’s share is Deerfield Management Company, LP. It holds Bioventus’s shares valued at 14M.

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis